A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

NCT06917508 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection
Drug Drug Interaction

Interventions

DRUG: EDP-323
DRUG: Midazolam
DRUG: Caffeine
DRUG: Rosuvastatin

Sponsor

Enanta Pharmaceuticals, Inc